Cartherics announces appointment of Dr Ian Nisbet as Chief Executive Officer
Posted: 28 November 2025 Cartherics Pty Ltd has announced that Dr Ian Nisbet has been appointed Chief Executive Officer as part of a planned leadership transition designed to support the company’s next phase of growth. The announcement followed…
Planet Innovation secures role in USD$25.1 million consortium advancing rapid mNGS respiratory diagnostic
Posted: 28 November 2025 Planet Innovation (PI) has been selected as a core technology partner in a USD$25.1 million international consortium formed to develop a rapid, point-of-care sequencing test for respiratory pathogens. Led by Ginkgo Bioworks, the group…
Amplia Therapeutics receives positive FDA feedback regarding planned Phase 2b/3 pancreatic cancer trial
Posted: 28 November 2025 Amplia Therapeutics Limited announced that positive feedback had been received from the United States Food and Drug Administration (FDA) following a recent Type D meeting, providing support for the company’s planned late-stage clinical trial…
WEHI’s new $8 Million PURPLE translational platform to accelerate new approaches to pancreatic cancer treatment
Posted: 28 November 2025 WEHI’s new groundbreaking digital platform uniting patients, clinicians and researchers was unveiled as a major step toward transforming pancreatic cancer care, supported through an $8 million philanthropic commitment from The Hemstritch Centre of Excellence…
AusBiotech’s Early-Stage Innovation Forum awarded to autoimmune biologic pioneer Professor Claudia Nold
Posted: 26 November 2025 A pioneering biologic aimed at interferon-driven autoimmune diseases was recognised with the top honour at this year’s Early-Stage Innovation Forum (ESIF), held during the AusBiotech International Conference 2025 in Melbourne. The accolade was awarded…
Peter Mac led study reveals new insights into how the brain’s barrier influences tumour behaviour
Posted: 26 November 2025 A new investigation from Peter MacCallum Cancer Centre is reported to have uncovered how cells forming the brain’s protective barrier act as “gatekeepers”, influencing how some brain tumours responded when nutrients were limited. Lead…
Telix Pharmaceuticals opens new manufacturing facility in Yokohama, Japan
Posted: 25 November 2025 Telix announced it has officially opened Telix Manufacturing Solutions (TMS) in Yokohama, Japan, marking the Company’s first cyclotron manufacturing facility in the Asia Pacific region. The site was established to expand access to radiopharmaceuticals…
Moderna Australia names CSIRO’s Dr Anne Klein as 2025 Fellow for advanced AI mRNA packaging project
Posted: 25 November 2025 Moderna Australia announced it has awarded the 2025 Moderna Australia Fellowship to Dr Anne Klein of the Commonwealth Scientific and Industrial Research Organisation (CSIRO). The annual initiative was designed to support emerging Australian scientists…
BioMelbourne Network AGM 2025: Connection, continuity and a clear path forward
Posted: 24 November 2025 BioMelbourne Network members, partners and supporters gathered high above Docklands at KPMG’s Tower Two for the 2025 Annual General Meeting (AGM) and networking event – an evening that blended strong governance with a clear…
Applications open for 2025-26 Premier’s Awards for Health and Medical Research
Posted: 21 November 2025 Applications are now open for the 2025-26 Premier’s Awards for Health and Medical Research (2025-26 Awards). Proudly supported by the Victorian Government, the awards recognise Victoria’s most talented early career health and medical researchers,…
CUREator BioMedTech Incubator funding round closing soon, offering up to $5 million per therapeutic project
Posted: 21 November 2025 CUREator BioMedTech Incubator has issued a final call for applications, with Expressions of Interest for the 2025 funding round set to close on Thursday 4 December 2025 at 2pm AEDT. Delivered in partnership with…
Aikenhead Centre for Medical Discovery marked major milestone with partner celebration event
Posted: 19 November 2025 The Aikenhead Centre for Medical Discovery (ACMD) marked a historic milestone, as partners, supporters and guests gathered to recognise the creation of Australia’s first hospital-integrated biomedical engineering research and education hub. Held ahead of…
